期刊文献+

甲磺酸阿帕替尼新辅助治疗局部晚期甲状腺乳头状癌一例报告并文献复习

A case report and literature review of neoadjuvant treatment of locally advanced papillary thyroid carcinoma with apatinib mesylate
原文传递
导出
摘要 大多数甲状腺乳头状癌经过适当手术治疗后预后良好,然而局部侵袭使手术治疗复杂化,并且有很高的术后复发率和死亡率[1]。7%~16%的甲状腺癌可直接侵犯喉、气管、食管、喉返神经以及颈部大血管等周围组织,也是分化型甲状腺癌最常见的致死原因之一[2]。因此,局部控制甲状腺浸润癌是一个重要的临床问题。
作者 石香玉 刘善廷 张莎莎 SHI Xiang-yu;LIU Shan-ting;ZHANG Sha-sha(Department of Head,Neck and Thyroid Surgery,Affiliated Hospital of Zhengzhou University,Henan Cancer Hospital,Zhengzhou 450000,China)
出处 《中华肿瘤防治杂志》 CAS 北大核心 2021年第16期1265-1270,共6页 Chinese Journal of Cancer Prevention and Treatment
关键词 阿帕替尼 甲状腺癌 新辅助治疗 靶向治疗 血管内皮生长因子受体2 酪氨酸激酶抑制剂 apatinib thyroid cancer neoadjuvant therapy targeted therapy vascular endothelial growth factor receptor 2 tyrosine kinase inhibitor
  • 相关文献

参考文献3

二级参考文献37

  • 1El Hajj H, Chehal A. El Saghir NS, et al. Recurrent GI bleeding and surgery following/he initial response to imalinib therapy in GIST of the stomach [ J ]. Dig Dis Sci, 2005,50(1):65-69.
  • 2Bonvalot S, Ehtweny H, Le Pechoux C, et al. Impact of surgery on adwmi,ed gastroinleslinal stromal tumors (GIST) in the imalinib era[J ]. Ann Surg Oncol,2006,13 ( 12 ): 1596-1603.
  • 3Andlbacka RH, Ng CS. Scaife CL, el al. Surgical resection of gasrointestinal stromal tumors after treatment with imalinib [J]. Ann Surg Oncol, 2007, 14(1): 14-24.
  • 4Joensuu H, Kellokumpu-Lehtinen PL. Bono P, et al. Adjuvant docetaxel or vinorelbine with or without trastuzumab for breasl cancer[ J ].N Engl J Med,2006,354( 8 ) :809-820.
  • 5Viani GA,Afonso SL, Stefano EJ, at al. Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials [J]. BMC Cancer, 2007,7(2):153.
  • 6Baselga J, Scmiglazov V. Manikhas GM, et al. Efficacy of neoadjuvanl trasluznmah in patients with inflammatory hreasl cancer: data from the NOAH (Neoadjuvant Herceptin) phase Ⅲ trial [ ahstraet 2030 ] [ J ]. Eur J Cancer, 2007,5 ( 2 ): 193.
  • 7Semiqlazov V, Eiermann W, Manikhas A, et al. Surgical aspect in NOAH phase Ⅲ trial (neoadjuvant trastuzumab in her2-positive locally advanced breast cancer)[J]. Eur J Cancer Suppl, 2008,6(2):169-170.
  • 8Pickels MD, Lowry. M, Manton DJ, el al. Role of dynamic contrast enhanced MRI in monitoring early response of locally ad- vanced breast cancer to breast neoadjuvant cheniotherapy [J]. Breast Cancer Res Treat, 2005,92( l ): 1-10.
  • 9Mazouni C, Hall A, Broglio K,, et al. Kinetics of Serum HER-2/ neu Changes in Patients With HER-2-Positive Primary Breast Cancer After lnitiati.n of Primary Chemotherapy [J ].Cancer. 2007,109(3):496-501.
  • 10Hotheinz RD, Horisberger K, Woernle C,et al. Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer[J]. lnt J Radiat Oncol Biol Phys,2006,66(5): 1384-1390.

共引文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部